2014

Hoping for "harmony" on global antibiotic resistance strategy

Week in review: Outcomes from WHA67

Progress on access to medicines at WHA67, but WHO funding sorely needed

World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

World Health Assembly 67: HAI intervention on access to essential medicines

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors

Tamiflu review shows desperate need for full clinical trials data transparency

New materials help assess medicines policies and interventions

A new (and improved) model to regulate pharmaceutical promotion

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed

Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed

2013

Bracing for another delay – open innovation at the WHO?

2011

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN

Conflicts of Interest and the Future of Financing for WHO.

Foundations: Conlicts of interests and Democracy issues

2010

Report exposes how Big Pharma has hijacked EU-India trade deal

Innovation & Access at the EU High Level Event on Global Health

HAI hosts essay competition for students

No NGO briefings will be allowed during World Health Assembly this year.